The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy
Abstract
Radiation therapy (RT) including external beam radiotherapy (EBRT) and internal radioisotope therapy (RIT) has been widely used for clinical cancer treatment. However, owing to the low radiation absorption of tumors, high doses of ionizing radiations are often needed during RT, leading to severe damages to normal tissues adjacent to tumors. Meanwhile, the RT efficacies are limited by different mechanisms, among which the tumor hypoxia‐associated radiation resistance is a well‐known one, as there exists hypoxia inside most solid tumors while oxygen is essential to enhance radiation‐induced DNA damages. With the development in nanotechnology, there have been great interests in using nanomedicine strategies to enhance radiation responses of tumors. Nanomaterials containing high‐Z elements to absorb radiation rays (e.g. X‐ray) can act as radio‐sensitizers to deposit radiation energy within tumors and promote treatment efficacy. Nanoscale carriers are able to deliver therapeutic radioisotopes into tumors for internal RIT, or chemotherapeutic drugs for synergistically combined chemo‐radiotherapy. As uncovered in recent studies, the tumor microenvironment could be modulated by various nanomedicine approaches to overcome hypoxia‐associated radiation resistance. Herein, the authors will summarize the applications of nanomedicine for RT cancer treatment, and pay particular attention to the latest development of ‘advanced materials' for enhanced cancer RT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–231 of 231
Brachytherapy Application With In Situ Dose Painting Administered by Gold Nanoparticle Eluters
Sinha, N., Cifter, G., Sajo, E., Kumar, R., Sridhar, S., Nguyen, P. L., Cormack, R. A., Makrigiorgos, G. M., & Ngwa, W. F. (2014) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.10.001 · Cited by 48
Brown, R., Tehei, M., Oktaria, S., Briggs, A., Stewart, C., Konstantinov, K., Rosenfeld, A. B., Corde, S., & Lerch, M. (2013) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201300276 · Cited by 46
Haffty, B. G., Son, Y. H., Wilson, L. D., Papac, R. J., FISCHER, D. B., Rockwell, S., Sartorelli, A. C., Ross, D. A., Sasaki, C. T., & Fischer, J. J. (1997) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1997)5:5<213::aid-roi1>3.0.co;2-0 · Cited by 44
Oxygen carriers and cancer chemo- and radiotherapy sensitization: Bench to bedside and back
Yu, M., Dai, M., Liu, Q., & Xiu, R. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2007.08.002 · Cited by 44
Targeted Nanomaterials for Radiotherapy
Escorcia, F. E., McDevitt, M. R., Villa, C. H., & Scheinberg, D. A. (2007) · Nanomedicine · doi:10.2217/17435889.2.6.805 · Cited by 44
In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer
Zhang, X., Yang, Gu, Chen, Rui, R., & Jiang, G. L. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s15997 · Cited by 44
Pandey, B. N., Shetake, N. G., Balla, M. M. S., & Kumar, A. (2016) · Journal of Radiation and Cancer Research · doi:10.4103/0973-0168.184606 · Cited by 44
Radiosensitization and Nanoparticles
Paunesku, T., Gutiontov, S. I., Brown, K., & Woloschak, G. E. (2015) · Cancer treatment and research · doi:10.1007/978-3-319-16555-4_7 · Cited by 42
Xie, Q., Lan, G., Zhou, Y., Huang, J., Liang, Y., Zheng, W., Fu, X., Fan, C., & Chen, T. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.07.046 · Cited by 42
Quantitative 3D Determination of Radiosensitization by Bismuth-Based Nanoparticles
Alqathami, M., Blencowe, A., Geso, M., & Ibbott, G. S. (2016) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2016.2183 · Cited by 41
Optimization of PEG coated nanoscale gold particles for enhanced radiation therapy
Cruje, C., Yang, C. J., Uertz, J., van Prooijen, M., & Chithrani, D. B. (2015) · RSC Advances · doi:10.1039/c5ra19104a · Cited by 40
Enhanced radiation therapy with internalized polyelectrolyte modified nanoparticles
Zhang, P., Qiao, Y., Wang, C., Ma, L., & Su, M. (2014) · Nanoscale · doi:10.1039/c4nr01564a · Cited by 39
Jin, C. S., Bai, L., Wu, H. Y., Liu, J., Guo, G., & Chen, J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.6.5912 · Cited by 37
Song, G., Li, C., Hu, J., Zou, R., Xu, K., Han, L., Wang, Q., Yang, J., Chen, Z., Qin, Z., et al. (2012) · Journal of Materials Chemistry · doi:10.1039/c2jm32382f · Cited by 37
Self-citationPolymeric nanoparticles for targeted radiosensitization of prostate cancer cells
Menon, J. U., Tumati, V., Hsieh, J., et al. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35300 · Cited by 36
Liposome encapsulated perfluorohexane enhances radiotherapy in mice without additional oxygen supply
Xu, L., Qiu, X., Zhang, Y., Cao, K., Zhao, X., Wu, J., Hu, Y., & Guo, H. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1033-3 · Cited by 35
Burger, N., Biswas, A., Barzan, D., Kirchner, A., Hosser, H., Hausmann, M., Hildenbrand, G. L., Herskind, C., Wenz, F. K., & Veldwijk, M. R. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.03.011 · Cited by 33
A magnetic vehicle realized tumor cell-targeted radiotherapy using low-dose radiation
Chen, H.-P., Tung, F.-I., Chen, M., & Liu, T.-Y. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.02.025 · Cited by 33
Comparative Dosimetric Evaluation of Nanotargeted 188 Re-(DXR)-Liposome for Internal Radiotherapy
Chang, C.-H., Stabin, M. G., Chang, Y., Chen, L., Chen, M., Chang, T., Lee, T., & Ting, G. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2008.0489 · Cited by 31
Improving chemoradiotherapy with nanoparticle therapeutics.
Eblan, M. J., & Wang, A. Z. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.08.04 · Cited by 31
Emerging targets for radioprotection and radiosensitization in radiotherapy
Kumar, S., Singh, R. K., & Meena, R. (2016) · Tumor Biology · doi:10.1007/s13277-016-5117-8 · Cited by 31
Shen, B., Zhao, K., Ma, S., Yuan, D., & Bai, Y. (2014) · Chemistry - An Asian Journal · doi:10.1002/asia.201403117 · Cited by 30
Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Harada, H., & Hiraoka, M. (2010) · Current Signal Transduction Therapy · doi:10.2174/157436210791920229 · Cited by 29
Nanomedicine in Chemoradiation
Miller, S., & Wang, A. Z. (2013) · Therapeutic Delivery · doi:10.4155/tde.12.147 · Cited by 28
Nuclear Targeting of Gold Nanoparticles for Improved Therapeutics
Yang, C. J., & Chithrani, D. B. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150701115012 · Cited by 28
Mühlhausen, U., Schirrmacher, R., Piel, M., Lecher, B., Briegert, M., Piée‐Staffa, A., Kaina, B., & Rösch, F. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050588q · Cited by 27
Folic acid-conjugated BSA nanocapsule (n-BSA–FA) for cancer targeted radiotherapy and imaging
Liang, S., Jin, X., Ma, Y., Guo, J., & Wang, H. (2015) · RSC Advances · doi:10.1039/c5ra12804h · Cited by 22
Chemoradiotherapy of Human Tumors: Novel Approaches from Nanomedicine
Werner, M. E., Foote, M. B., & Wang, A. Z. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800626229 · Cited by 16
Blatnik, J., Luebke, L., Simonet, S., Nelson, M., Price, R., Leek, R., Zeng, L., Wu, A., & Brown, E. (2012) · Microscopy and Microanalysis · doi:10.1017/s1431927611012414 · Cited by 15
Targeted molecular brachytherapy
Mayers, G. L. (2006) · Drug Development Research · doi:10.1002/ddr.20070 · Cited by 8
Hainfeld, J. F., O’Connor, M. J., Lin, L., Slatkin, D. N., Dilmanian, F. A., & Smilowitz, H. M. (2014) · Cancer Research · doi:10.1158/1538-7445.am2014-851 · Cited by 3
Cited by
Reactive Oxygen Species (ROS)-Based Nanomedicine
Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,443
Second near-infrared photothermal materials for combinational nanotheranostics
Xu, C., & Pu, K. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00664e · Cited by 941
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Xuan, L., Ju, Z., Skonieczna, M., Zhou, P., & Huang, R. (2023) · MedComm · doi:10.1002/mco2.327 · Cited by 807
Molecular Imprinting: Green Perspectives and Strategies
Arabi, M., Ostovan, A., Li, J., Wang, X., Zhang, Z., Choo, J., & Chen, L. (2021) · Advanced Materials · doi:10.1002/adma.202100543 · Cited by 780
Metadata
- Authors
- Song, G., Cheng, L., Chao, Y., Yang, K., & Liu, Z.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2017-06-23
- Volume
- 29
- Issue
- 32
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2632077510
- Cited by
- 771
- References
- 231
- FWCI
- 40.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.